| For: | Deng Z, Teng YJ, Zhou Q, Ouyang ZG, Hu YX, Long HP, Hu MJ, Mei S, Lin FX, Dai XJ, Zhang BY, Feng T, Tian XF. Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(11): 1725-1740 [PMID: 34853646 DOI: 10.4251/wjgo.v13.i11.1725] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i11/1725.htm |
| Number | Citing Articles |
| 1 |
Huan Chen, Jing Chen, Huixin Yuan, Xiuhui Li, Weihua Li. Hypoxia‑inducible factor‑1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma (Review). Oncology Letters 2022; 24(2) doi: 10.3892/ol.2022.13404
|
| 2 |
Yuehan Zhou, Jinzhan Lou, Yuqin Tian, Jinlei Ding, Xiaobo Wang, Bo Tang. How lactate affects immune strategies in lymphoma. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1480884
|
| 3 |
Yan Chen, Yan Zhu, Zihu Tan, Xueyi Zhang, Jiafeng Hu, Ruichi Zhu, Minjie Xie, Jing Wang, Lizhu Chen, Zhenli Guo. Jiajian Shuyu pills effectively ameliorate cognitive impairment via regulating the inflammation of microglia in an Alzheimer's disease mouse model. Journal of Ethnopharmacology 2025; 343 doi: 10.1016/j.jep.2025.119508
|
| 4 |
Zishu Zhang, Heyun Tao, Kexin Mao, Fanying Meng, Shanghong Jiang, Junyi Chen, Xinmiao He, Xuefei Tian. The Central Qi theory in traditional Chinese medicine: Gut microbiota modulation as a strategic target for hepatocellular carcinoma therapy. Journal of Ethnopharmacology 2026; 360 doi: 10.1016/j.jep.2025.121147
|
| 5 |
Shouze Liu, Qianqian Zhang, Wenhua Liu, Xianghua Huang. Research on the mechanisms of Shu Yu wan in the treatment of cervical cancer based on network pharmacology analyses and molecular docking technology. Natural Product Research 2023; 37(4) doi: 10.1080/14786419.2022.2071884
|
| 6 |
Shujing Zhang, Yuemeng Sun, Jiarou Wang, Yixing Lu, Huimin Yuan, Yulin Zong, Haoyu Zhu, Yang Tang, Yan Sun, Fengjie Zheng, Yuhang Li. Shuyu decoction exhibits anti-fatigue properties via alleviating exercise-induced immune dysfunction. Journal of Ethnopharmacology 2024; 319 doi: 10.1016/j.jep.2023.117259
|
| 7 |
Chan Mo, Min Hong, Yunjia Li, Danping Huang, Qingyu Ji, Yuan Liu. Low Indoleamine 2,3-Dioxygenase 1 Expression Enhances Dendritic Cells Response to Tumor Cells Against Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2025; doi: 10.2147/JHC.S530997
|
| 8 |
Xuecheng Yu, Yonggui Wu, Wenlong Su, Jingyue Tang, Qingsong Yang, Peng Huang, Binbin Zhao, Guosheng Cao, Qiong Yang. Jiajian Shuyu Pills ameliorates cerebral ischemia-reperfusion injury by regulation hippo signaling and the lipid metabolism-ferroptosis axis. Journal of Ethnopharmacology 2027; 372 doi: 10.1016/j.jep.2026.122223
|
| 9 |
Sheng Chen, Jing Wen, Zhengyi Liu, Yuxiang Hu, Chenhong Zhu, Xiao Yang, Zhi Wen, Cai Tan, Yaoyao Li, Anqi Xiao, Shuying You, Tonglin Sun, Hua Liu, Yinhui Sun, Lihuai Wang. A Novel Strategy for Enhancing Lung Cancer Immunotherapy Efficacy: Traditional Chinese Medicine Formula Shuyu Pills Enhances Anti-PD-1 Efficacy Via the “GM-ERS-Immunity” Axis. Biological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00314-0
|
| 10 |
Yijia Liu, Yanzhe Huang, Hongliang Luo, Xueqin Lin. The roles of Cryptochrome-1: the circadian clock as a control point in cancer therapy. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06702-0
|
| 11 |
Huilan Zheng, Gang Wang, Ming Liu, Hongbin Cheng. Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1168226
|
| 12 |
Yinping Zeng, Jiajun Huang, Tingting Duan, Xiaofeng Wang. Astragaloside IV inhibits nasopharyngeal carcinoma progression by inhibiting SATB2/Wnt/PD-L1 pathway and enhancing the killing activity of T cells. European Journal of Histochemistry 2026; 70(2) doi: 10.4081/ejh.2026.4540
|
| 13 |
Muhammad Tufail, Can-Hua Jiang, Ning Li. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02280-1
|
| 14 |
Yan Zhao, Cheng Xing, Yating Deng, Can Ye, Hongling Peng. HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies. Genes & Diseases 2024; 11(1) doi: 10.1016/j.gendis.2023.02.039
|
| 15 |
Wei Peng, Kai Xiong, Yuyang Zheng, Jiahan Zheng, Yuanyuan Zhong, Jihao Yang, Yuchuan Jiang. Polysaccharides-gut microbiota interaction: mechanisms regulating the hepatocellular carcinoma immune microenvironment. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1789273
|